跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIMP
首页
药物
TIMP
TIMP
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Modified timp
申请人: ORIENTAL YEAST CO LTD
优先权: 1999
US
Compounds
申请人: IMP INNOVATIONS LTD
优先权: 2005
CN
US
2 件公开
Use of TIMP-3 inducers of TIMP-3 expression, and TIMP-3 mimetics to treat ocular neovascularization
申请人: ALCON INC
优先权: 2000
US
Human TIMP-1 antibodies
申请人: BAYER AG
优先权: 2002
US
9 件公开
Compositions for inhibiting teratoma formation and growth comprising TIMP-1 and TIMP-2 as effective components
申请人: UNIV KOREA RES & BUS FOUND
优先权: 2018
US
Use of timp-1 as an immunosuppressive
申请人: BERDEL WOLFGANG E
优先权: 2001
US
Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
申请人: AMGEN INC
优先权: 2003
US
6 件公开
USE OF ANTIBODIES TO TIMP-2 FOR THE IMPROVEMENT OF RENAL FUNCTION
申请人: ASTUTE MEDICAL INC
优先权: 2016
CN
药物
反馈